. However, the consequences of dual ATPase subunit loss on mSWI/SNF complex subunit composition, chromatin targeting, DNA accessibility and gene expression remain unknown. Here we identify an ATPase module of subunits that is required for functional specification of the Brahma-related gene-associated factor (BAF) and polybromo-associated BAF (PBAF) mSWI/SNF family subcomplexes. Using SMARCA4/2 ATPase mutant variants, we define the catalytic activitydependent and catalytic activity-independent contributions of the ATPase module to the targeting of BAF and PBAF complexes on chromatin genome-wide. Finally, by linking distinct mSWI/SNF complex target sites to tumor-suppressive gene expression programs, we clarify the transcriptional consequences of SMARCA4/2 dual loss in SCCOHT.
To define mSWI/SNF complex size and composition following dual loss of the SMARCA4 and SMARCA2 ATPases, we leveraged two cell line models of SCCOHT: BIN-67 (refs. 8, 9 ) and SCCOHT-1 (ref. 10 ), which we confirmed to be deficient in the proteins SMARCA4 and SMARCA2 ( Supplementary Fig. 1a ). Using density sedimentation of nuclear extracts coupled with immunoblotting, we observed that a subset of remaining mSWI/SNF subunits co-sedimented in the absence of SMARCA4 and SMARCA2 ( Fig. 1a and Supplementary  Fig. 1b) , eluting in lower molecular-weight fractions than wildtype (WT) BAF and PBAF mSWI/SNF family subcomplexes ( Supplementary Fig. 1c ). We confirmed that this co-sedimentation profile was a result of direct interaction between remaining subunits, and that residual complexes preserved mutually exclusive occupancy of subcomplex-specific subunits such as ARID1A (BAF-specific) and ARID2 (PBAF-specific) ( Supplementary Fig. 1d ).
To comprehensively define the components of the residual complex, we performed immunoprecipitations from SCCOHT-1 nuclear extracts and subjected eluted proteins to mass-spectrometry-based proteomic analysis ( Fig. 1b and Supplementary Table 1 ). These studies defined two groups of mSWI/SNF subunits: residual complex components whose interactions were preserved in the absence of SMARCA4/2 ATPase subunits (ARID1A, ARID2, SMARCB1, SMARCC1/2, SMARCD1/2/3, SMARCE1, DPF2, GLTSCR1/L and BRD7/9), and subunits that required SMARCA4/2 for complex binding (ACTL6A, BCL7A/B/C, PBRM1 and SS18), which we termed ' ATPase module' subunits. We replicated these results in the SMARCA4/2-deficient SW-13 cell line 11 , in which purified mSWI/ SNF complexes similarly eluted at a lower molecular weight (Fig. 1c) and selectively lacked ATPase module subunits ( Supplementary  Fig. 1e ), consistent with parallel studies from our laboratory 12 as well as independent demonstrations that ACTL6A is destabilized following loss of SMARCA4/2 (refs. 13, 14 ). Given that the subunits of the residual complex contain numerous DNA-binding domains (such as the HMG domain of SMARCE1, winged helix domain of SMARCB1), we tested for residual genomic targeting in the BIN-67 cell line by using chromatin immunoprecipitation followed by sequencing (ChIP-seq). Subunits in the residual complex (SMARCC1, DPF2, ARID2) bound accessible chromatin regions defined by an assay for transposase-accessible chromatin using sequencing (ATAC-seq) (Fig. 1d ) such as active transcriptional start sites (TSSs) ( Supplementary Fig. 1f,g ). In contrast, ChIPseq performed on ATPase module subunits (SS18, SMARCA4) returned almost no significant peaks in these regions (Fig. 1e) , consistent with their absence from the complex and confirming the high specificity of the mSWI/SNF ChIP-seq studies performed.
To test whether loss of SMARCA4/2 would alter the essentiality of other mSWI/SNF subunits for cell proliferation, we performed genome-scale CRISPR-Cas9 fitness screening in the BIN-67 cell line 15 . Using a statistical framework to call genetic interactions from cancer cell line fitness screening data 16 , we found that mSWI/SNF complex members were significantly less essential in SMARCA4/2-dual-deficient cell lines (BIN-67, as well as COV434, OVK18, H1581, H23 cell lines) compared to mSWI/SNF-intact cell lines (SMARCB1, P = 1.3 × 10 SMARCC1  SMARCC2  SMARCD1  ARID2  SMARCB1  SMARCE1   10% 30% Glycerol I n p u t SCCOHT-1 (dual ATPase-deficient) 2 Supplementary Fig. 7a . All molecular weights are reported in kilodaltons (kDa). b, Peptides corresponding to mSWI/SNF subunits identified in immunoprecipitation/mass spectrometry from SCCOHT-1 nuclear extract. SMARCC1 and SMARCD1 immunoprecipitations identified a cohort of subunits that remained stably bound to complexes in the absence of both ATPase subunits. c, Silver stain of density sedimented, endogenously purified BAF complexes from SMARCA4/2-intact (293T) and SMARCA4/2-deficient (SW-13) cell lines, using an HA-tagged DPF2 subunit as bait. d, Heatmaps of chromatin accessibility (ATAC-seq) and residual mSWI/SNF occupancy (ChIP-seq) in the BIN-67 cell line, treated with a control GFP vector. Each row of the heatmap corresponds to a peak from the union of ATAC-seq and SMARCC1 ChIP-seq peaks in this condition. Rows are rank ordered by SMARCC1 occupancy. Each column shows the normalized read density for different experimental conditions across a 4-kilobase (kb) window centered at each peak. e, Heatmaps reflecting SS18 and SMARCA4 ChIP-seq experiments performed in the BIN-67 cell line. f, Genetic interaction data derived from CRISPR-Cas9-based screens performed in SMARCA4/2-dual-deficient and SMARCA4/2-intact cell lines reported as a Pi-score, which measures the difference between the expected and observed fitness phenotypes upon knockout. Negative scores denote synthetic lethality, and positive scores denote alleviating interactions. Significance was calculated by a two-sided Wilcoxon rank-sum test on the SMARCA4/2-deficient lines (n = 5) against the WT lines (n = 386). The false discovery rate cutoff was 0.25 after Benjamini-Hochberg correction was used. g, Schematic of residual mSWI/SNF complex composition in the absence of the SMARCA4/2 ATPase subunits.
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NATURe GeNeTICS Table 2 ). We also recovered synthetic lethal relationships with PRC2 complex subunits, which have recently been reported 17, 18 ( Fig. 1f and Supplementary Fig. 1h ). Taken together, these results suggest that mSWI/SNF complexes exhibit a modular biochemical organization, and that the absence of the ATPase module causes BAF-and PBAF-specific subunits to co-elute as similarly sized PBRM1   SMARCA4   ARID1A   SMARCC2  SMARCD1  PBRM1   10%  30%  Glycerol   In  p u t  2  3  4  5  6  7  8  9  10 11  12 13 14 15 16 17 18 19 20 21 22 Residual complex BAF expected PBAF expected Supplementary Fig. 7b . c, Log-scale scatterplot showing the normalized read counts from DPF2 and ARID2 ChIP-seq across a union set of DPF2 and ARID2 peaks (inset). Spearman correlation (cor) is shown. d, Overlap between SS18 and ARID2 peaks in the SMARCA4 rescue condition in BIN-67 cells. e, Log-scale scatterplot showing the normalized read counts from SS18 and ARID2 ChIP-seq across a union set of SS18 and ARID2 peaks following SMARCA4 rescue. f. Heatmaps reflecting ChIP-seq occupancy for SMARCC1, ARID2, DPF2, SS18 and SMARCA4 in control and SMARCA4 rescue conditions, split between SS18-only, ARID2-only and shared occupancy. Rows are rank ordered by SMARCC1 occupancy in the control condition. g, Distribution of mSWI/SNF peaks over genomic features in control and SMARCA4 rescue conditions.
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non-essential residual complexes that retain binding to accessible chromatin (Fig. 1g) .
Given that the large majority (three-quarters) of the subunits are common to both BAF and PBAF subcomplexes, the mechanisms by which mSWI/SNF subunits form functionally differentiated assemblies remain unknown. The modularity of the mSWI/SNF complex we identified suggested the possibility that the residual complex, once loaded with subcomplex-specific subunits, could attach to an 
23
) shows proximity to a crystalized ATP mimic. Top: overall structure of the Swi2 domain, with mutated residues highlighted. Bottom: enhanced view of ATP-binding pocket in the presence of an ATP mimic. b, Scatterplots of differential accessibility under SMARCC1 peaks following rescue of different ATPase WT and mutant variants. Each point in the scatterplot corresponds to a SMARCC1 peak called in the BIN-67 SMARCA4 rescue condition. Each axis displays the fold change in accessibility under each peak (as measured by ATAC-seq reads per million mapped to that peak) as compared to the control condition. Spearman correlation is shown. c, Stacked bar plot of the proportion of BAF and PBAF peaks that are activity-dependent and activity-independent. Fisher's two-sided exact test performed on total ChIP-seq peaks (n = 22,709), ***P < 1 × 10 -3
. d, Heatmaps of chromatin accessibility and mSWI/SNF occupancy across ARID2 peaks gained following rescue of a SMARCA4 allelic series. The ARID2 peak set is split into two groups: activity-independent and activitydependent peaks. Rows are rank ordered by ARID2 occupancy in the WT rescue condition. e, Heatmaps of chromatin accessibility and mSWI/SNF occupancy across SS18 peaks that were gained following rescue of a SMARCA4 allelic series. The SS18 peak set is split between activity-independent and activity-dependent peaks. Rows are rank ordered by SS18 occupancy in the WT rescue condition. f, Box plots showing normalized read counts across SS18 activity-independent (n = 3,721) and activity-dependent peaks (n = 14,814). First and third quartiles are denoted by lower and upper hinges. Whiskers extend to the smallest and largest values within 1.5× the interquartile range from the lower and upper hinges.
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ATPase module containing either SS18 or PBRM1 (known to be mutually exclusive in BAF and PBAF complexes, respectively 19, 20 ), enabling functional specificity (Fig. 2a) . We confirmed that rescue of SMARCA4/2 in SW-13 cells sufficiently restored the protein level abundance of ATPase module subunits ( Supplementary  Fig. 2a ) in a manner that was dose-dependent ( Supplementary  Fig. 2b ) and correlated with the overall abundance of SMARCA4 (correlation in immunofluorescence signal, Spearman P = 0.860, Supplementary Fig. 2c ). The presence of SMARCA4 also restored interactions between ATPase module subunits and residual complex components ( Supplementary Fig. 2d ), including BAF-specific ARID1A-SS18 binding and PBAF-specific ARID2-PBRM1 binding ( Supplementary Fig. 2e,f) .
Further, we found that BAF and PBAF complexes required the ATPase module for their distinct biochemical size profiles as well as their genomic targeting patterns on chromatin. Restoration of the ATPase module in SW-13 cells resulted in clear size separation between BAF and PBAF complex subunits (Fig. 2b) , implying complete assembly of both complexes. In BIN-67 control cells, genome-wide occupancies of BAF-and PBAF-specific subunits were strongly correlated (Spearman P = 0.839, Fig. 2c ). This suggested that the residual complexes lacked the distinguishing features of BAF or PBAF despite the presence of subcomplex-specific subunits (such as ARID1A/DPF2 for BAF or ARID2/BRD7 for PBAF). Restoration of the ATPase module increased chromatin affinity of both complexes ( Supplementary Fig. 2g ) and led to gains in the number of significant mSWI/SNF peaks ( Supplementary Fig. 2h ), which were predominantly non-overlapping between BAF and PBAF ( Fig. 2d,e) . This finding is consistent with those from previous mSWI/SNF subunit reintroduction studies in cancer cells 21 (although higher overlap between subcomplexes at promoters has been observed in mSWI/ SNF-intact cell lines 22 ). These results indicate that integration of the ATPase module is required for BAF and PBAF complexes to target divergent genomic loci (Fig. 2e,f) , as demonstrated by the shift in PBAF localization toward TSSs and enrichment of BAF peaks distal to TSSs following SMARCA4 rescue (Fig. 2g) .
We next investigated how the ATPase module mediates divergent BAF and PBAF complex localization. Rescue of the ATPase subunit chr10:100,015,611-100,031,958 
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introduces two concurrent changes to mSWI/SNF complexes: (1) restored biochemical composition of the complex and (2) restored ATPase catalytic activity. To distinguish the relative contributions of these two events on BAF and PBAF localization and function, we rescued BIN-67 cells with either WT or ATPase-mutant SMARCA4 (Fig. 3a) 23,24
. SMARCA4 T910M and SMARCA4 K785R mutants exhibited levels of protein expression similar to those of WT SMARCA4 ( Supplementary Fig. 3a ) and recapitulated WT complex biochemical composition ( Supplementary Fig. 3b ) as previously shown 24, 25 . However, they exhibited either partial (T910M) or complete (K785R) losses of catalytic activity as assessed by in vitro ATPase assays ( Supplementary Fig. 3c ) and genome-wide chromatin accessibility profiles following expression BIN-67 cells (Fig. 3b) . Expression of either mutant variant resulted in partially reduced affinity of mSWI/SNF complexes to chromatin as compared to expression of WT SMARCA4 ( Supplementary Fig. 3d ).
To assess whether gains in BAF and PBAF complex targeting can occur in the presence of the ATPase module but in the absence of ATPase activity, we mapped the localization of mSWI/ SNF complexes by using ChIP-seq following rescue of ATPasedead SMARCA4 K785R (Fig. 3c) . Strong experimental agreement between SMARCA4 and SMARCC1 antibodies targeting mSWI/ SNF complexes was detected in all reintroduction conditions ( Supplementary Fig. 3e ). Unexpectedly, rescue with SMARCA4 K785R in BIN-67 cells was sufficient to target mSWI/SNF complexes to a subset of sites that were gained following rescue of WT SMARCA4, and these sites were similar to the BAF-and PBAFspecific chromatin binding profiles observed with WT SMARCA4 rescue ( Supplementary Fig. 3f) .
From this observation, we defined catalytic activity-dependent sites as those that were gained following SMARCA4 WT rescue but not following SMARCA4 K785R rescue. We defined catalytic activity-independent sites as those that were gained in both rescue conditions (Fig. 3a) . We further subdivided these peaks into BAFand PBAF-specific sites by using the overlap between SMARCA4 and either SS18 (BAF) or ARID2 (PBAF) in the same condition, ensuring that each site represented high-confidence co-localization between at least two subunits of the same complex. We found that BAF and PBAF complexes exhibited significantly different proportions of activity-independent sites, with the majority of PBAF sites (~60%) but the minority of BAF sites (~20%) exhibiting activity-independent localization (Fisher's test P < 2.2 × 10 -16 , Fig. 3c ). Over these BAF and PBAF activity-independent sites (Fig. 3d,e) , both the SMARCA4 K785R and SMARCA4 T910M mutants exhibited genomic occupancy comparable to that of WT SMARCA4, although only the T910M mutant created partial chromatin accessibility under those sites, due to its partial ATPase activity (Fig. 3f) . In contrast, at activity-dependent sites, only WT SMARCA4 was capable of generating mSWI/SNF de novo genomic occupancy and creating accessible sites (Fig. 3f) .
We then examined the role of these sites at BAF complexoccupied enhancers. We found that 10% of all enhancers in BIN-67 cells were targeted by BAF in an activity-independent manner and an additional ~30% in an activity-dependent manner (Fig. 4a) . We found that catalytically deficient BAF complexes containing SMARCA4 T910M could target sites that were enriched for H3K4me1 and, to a lesser extent, H3K27ac activating marks (Fig. 4b) , suggesting that the ATPase module directly or indirectly recognizes pre-established enhancer elements. However, catalytically deficient BAF complexes could not target sites where these activating marks were absent (Fig. 4b) . These sites are neither heterochromatic nor silenced, as they lacked the H3K9me3 or H3K27me3 mark, respectively ( Supplementary Fig. 4a ). At these sites, WT ATPase activity was essential for targeting, and substantial increases in H3K4me1 and H3K27ac marks as well as recruitment of MLL3/4 methyltransferases (Fig. 4c ) occurred following remodeling (ATAC-seq data shown in Fig. 3e ). In particular, because the SMARCA4 T910M mutant exhibited partial remodeling ability (Fig. 3b) yet did not localize to activity-dependent sites, we conclude that full remodeling activity is necessary for enhancer activation at these sites (Fig. 4c,d ). These data suggest that previous models positing that H3K4me1 is required for BAF targeting are probably overly simplistic 26 , because BAF complex ATPase activity following SMARCA4 rescue precedes the establishment of H3K4me1 by MLL3/4 in the majority of gained sites.
We also observed activity-independent effects for PBAF complexes following rescue of the ATPase module. At PBAF-occupied TSS regions (within 4 kb of the TSS, Fig. 5a ), rescue of the ATPase module resulted in the directional extension of PBAF occupancy into gene bodies, for example at the ETHE1 locus (Fig. 5b) . This directional extension resulted in marked increases in genomewide PBAF peak width and occurred irrespective of whether the for genes in these three clusters. Enrichment was calculated by hypergeometric testing after Benjamini-Hochberg false discovery rate correction by the GOrilla package. d, RNA-seq data from SCCOHT patient tumors were compared to primary ovarian samples from the GTEx consortium to generate two gene sets: genes that were preferentially abundant in normal ovarian tissue (red) and those that were preferentially abundant in SCCOHT tumor samples (blue). e, Top: scatterplot of BIN-67 differential expression data restricted to genes that were preferentially abundant in normal ovarian tissue. Bottom: scatterplot of BIN-67 differential expression data restricted to genes that were preferentially abundant in SCCOHT tumor samples. The Wald test followed by Benjamini-Hochberg false discovery rate correction was used to report significance (implemented by the DESeq2 package). ).
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ATPase was catalytically active, dead (K785R) or deficient (T910M) (Fig. 5c) . Notably, the extent of PBAF spreading was concomitant with (and did not alter) the directional signatures of active transcription present at most promoters 27 , high H3K27Ac (Fig. 5d ) and depletion of H3K4me1 (Supplementary Fig. 4b) . A comparatively small percentage (<1%, Fig. 5a ) of TSS regions encompassed activity-dependent sites (Supplementary Fig. 4c ). Taken together, these data suggest that the ATPase module on PBAF complexes enables recognition of transcriptional initiation signatures in a manner independent of catalytic activity.
Next, to assess the gene regulatory effects of mSWI/SNF catalytic activity at these TSS and enhancer elements, we performed RNA sequencing (RNA-seq) on BIN-67 cells in SMARCA4 WT and rescue conditions. In contrast to other enzymatic chromatin regulatory complexes such as MLL3/4 (ref. 28 ), we found that the large majority of mSWI/SNF-driven gene expression changes in BIN-67 required mSWI/SNF enzymatic activity, with a sevenfold increase in the number of upregulated genes identified between WT SMARCA4/2 and SMARCA4 mutant rescue conditions (Fig. 6a, Supplementary  Fig. 5a and Supplementary Table 3 ). The downregulated, upregulated and highly upregulated gene sets as defined by hierarchical clustering differed in their requirements for direct targeting by mSWI/SNF family complexes. Downregulated genes, which were predominantly involved in cell cycle and chromosome segregation (that is, BUB1B, CENPA, E2F2, FOXM1, et cetera), were not enriched for nearby BAF or PBAF complex localization relative to non-changing genes (Fig. 6b) , suggesting that these gene changes were secondary downstream effects of SMARCA4 rescue. Highly upregulated genes involved in keratinization and other stimulus response genes ( Fig. 6c and Supplementary Fig. 5b ) were positively enriched for nearby BAF and PBAF complexes whose localization depended on their ATPase activity (Fig. 6b) , implying that these genes are targets of de novo enhancers created by both complexes. Finally, we found that PBAF and BAF activity-dependent and activity-independent targeting collaborated in upregulation of the remaining upregulated genes (Fig. 6b ), which were involved in senescence and extracellular structure, cell migration and epithelial-mesenchymal transition ( Fig. 6c and Supplementary Fig. 5c,d) .
Importantly, the gene expression changes following SMARCA4/2 rescue corroborate transcriptional signatures found in SCCOHT patient tumors. We analyzed tumor RNA-seq from SCCOHT primary tumors from a previous study 6 and compared these to transcriptional profiles from normal ovarian tissue 29 (Fig. 6d) . We found that genes that were preferentially abundant in normal ovarian tissue highly overlapped with genes that were upregulated following the restoration of SMARCA4 or SMARCA2 to BIN-67 cells (Fig. 6e) , and that genes that were preferentially abundant in SCCOHT tumors were downregulated following SMARCA4/2 rescue in BIN-67 cells (Fig. 6e) . This overlap was statistically significant (Fig. 6f, ). To summarize, by leveraging cell line models of the rare ovarian cancer SCCOHT, we have uncovered several principles underlying mSWI/SNF complex targeting and function. In the absence of the SMARCA4/2 subunits, mSWI/SNF complexes were reduced to a residual assembly with a baseline affinity to chromatin but lacking the distinguishing properties of BAF and PBAF subcomplexes. (Supplementary Fig. 6) . Surprisingly, reintroduction of ATPasedeficient SMARCA4 restored mSWI/SNF localization to ~25% of its target sites and re-established differential localization of BAF and PBAF complexes to pre-marked enhancers and transcription initiation sites, respectively. ATPase-driven DNA accessibility is responsible for the remaining 75% of gained sites, particularly for BAF complexes, which also do not require pre-marked H3K4me1 for targeting to these sites. These ATPase activity-mediated events rewire the transcriptional state of SCCOHT cells toward tumorsuppressive gene expression programs found in normal ovarian tissue, providing a mechanistic context behind SMARCA4/2 dual loss in SCCOHT. . 17874 ). The T910M SMARCA4 mutant was created using overlap PCR performed on the WT SMARCA4 clone using a custom set of internal primers to introduce the T910M mutation, which was subcloned into a modified pTight (Clontech) and pLEX307 backbone. Oligonucleotides used for this protocol are included in Supplementary Table 4 . A pLEX307 vector expressing green fluorescent protein was used as an overexpression control.
Online content
Lentiviral infection.
The packaging vectors pspax2 and pMD2.G were cotransfected with pLEX307 vector containing the clone of interest into HEK-293T cells, using polyethylenimine as a transfection reagent. Cells were incubated for 72 h, and the media were filtered with a 0.4 µm filter before being either concentrated with an ultracentrifuge (20,000 r.p.m. for 2.5 h) or added directly to cells plated at 70% confluence with 1:1,000 of 10 mg ml -1 protamine sulfate.
Whole-cell lysates. Trypsinized cells (1 × 10 6 ) were washed twice in PBS and suspended in cold radioimmunoprecipitation assay buffer (10 mM Tris/Cl (pH 7.4), 1 mM EDTA (pH 7.4), 300 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 0.1% sodium deoxycholate, 1 mM dithiothreitol and 1 mM phenylmethanesulfonyl fluoride (PMSF) and rotated for 30 min at 4 °C.
Nuclear extracts.
After trypsinization, cells were incubated in Buffer A (25 mM HEPES pH 7.6, 5 mM MgCl 2 , 25 mM KCl, 0.05 mM EDTA, 10% glycerol and 0.1% NP-40 with protease inhibitor (Roche), 1 mM dithiothreitol (DTT) and 1 mM PMSF) for 10 min, and the pellets were resuspended in 600 μl of Buffer C (10 mM HEPES pH 7.6, 3 mM MgCl 2 , 100 mM KCl, 0.5 mM EDTA and 10% glycerol with protease inhibitor, 1 mM DTT and 1 mM PMSF) with 67 μl of 3 M (NH 4 ) 2 SO 4 for 20 min. The lysates were spun down using a tabletop ultracentrifuge at 100,000 r.p.m. at 4 °C for 10 min. Nuclear extracts were precipitated with 200 mg of (NH 4 ) 2 SO 4 on ice for 20 min and finally purified as pellets by ultracentrifugation at 100,000 r.p.m. at 4 °C for 10 min. The pellets were resuspended in IP buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1 mM EDTA and 1% Triton X-100 with protease inhibitor, 1 mM DTT and 1 mM PMSF) for subsequent experiments.
Density sedimentation gradient. Nuclear extract (800 μg, quantified by Bradford assay) was resuspended in 200 μl of 0% glycerol HEMG buffer (supplemented with protease inhibitors and DTT) and overlaid onto a 11 ml 10-30% glycerol (in HEMG buffer) gradient prepared in a 14 × 89 mm polyallomer centrifuge tube (Beckman Coulter, No. 331327). Tubes were centrifuged in an SW40 rotor at 4 °C for 16 h at 40,000 r.p.m. Fractions (0.550 ml) were collected and used in immunoblot analyses.
Immunoprecipitation. Immunoprecipitations were performed with 100 ug of nuclear extract resuspended in standard immunoprecipitation buffer (150 mM NaCl, 1 mM EDTA, 1% Triton X-100) and rotated overnight with 1.25 µg antibody. Antibodies to the following were used: SMARCA4 (Santa Cruz, No. G-7; Abcam, No. ab110641, used in Supplementary Fig. 2f) Mass-spectrometry. For proteomic analysis, antibodies against SMARCA4, SMARCD1 and SMARCC1 were crosslinked with dimethyl pimelimidate to Protein G GammaBind Sepharose beads (GE) before immunoprecipitation from SCCOHT-1 nuclear extract. Bait protein was eluted with high salt and urea buffer, followed by trypsin digest and mass-spectrometry (Thermo Exactive Plus Orbitrap) as performed previously 12 .
Purification of complexes.
Complexes were purified as previously described, with few modifications 30 . SW-13 and 293 T cell lines stably expressing HA-DPF2 constructs were cultured in 150 mm dishes and expanded. Cells were scraped and washed with cold PBS. The suspension was centrifuged at 3,000 r.p.m. for 5 min at 4°C and pellets were resuspended in hypotonic buffer (HB) containing 10 mM Tris-HCl pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM DTT and 1 mM PMSF, and incubated on ice for 5 min. Nuclear pellets were resuspended in high salt buffer containing 50 mM Tris-HCl pH 7.5, 300 mM KCl, 1 mM MgCl 2 , 1 mM EDTA, 1 mM, 1% NP-40, 1 mM DTT, 1 mM PMSF and protease inhibitor cocktail. The homogenate was incubated on a rotator for 1 h. Homogenates then were centrifuged at 20,000 r.p.m. (30,000 g) for 1 h at 4 °C using a SW32Ti rotor. The nuclear extract was filtered through a 0.45 µm filter and incubated overnight with anti-HA beads (Pierce, 88836) before elution with HA peptide. Eluted material was then subjected to density gradient centrifugation. Senescence staining. BIN-67 cells treated with SMARCA4 and SMARCA2 lentivirus for two weeks post selection were fixed and stained as described in the Senescence β-Galactosidase Staining Kit (Cell Signaling Technologies) alongside a naïve control.
Immunoblot. Protein was loaded onto
Generation of knockout HEK-293T cell lines. CRISPR-Cas9 KO constructs targeting SMARCA4 and SMARCA2 were purchased from Santa Cruz and cotransfected into HEK-293T cells by using the reagent Lipofectamine 3000. Cells were selected with puromycin at 2 µg ml -1 for 5 d. Single-cell clones were selected and screened for loss of subunit expression by using immunoblotting. ATP consumption assay. Constructs expressing SMARCA4 WT, K785R, T910M and an empty vector control were transiently expressed in naïve 293 T cells for 72 h. Cells were trypsinized and pooled in batches of 50 million cells each, followed by PBS wash. Cells were treated with nuclear extract buffer A (25 mM HEPES pH 8.0, 5 mM MgCl 2 , 25 mM KCl, 0.05 mM EDTA, 10% glycerol, 0.1% NP-40) and resuspended in 200-300 µl of lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 0.1% NP-40) with protease inhibitor and incubated in a cold room with constant rotation for 30 min. Cell debris was discarded by ultracentrifuging at 100,000 r.p.m. for 5 min. The supernatant was collected, quantified and used for the subsequent overnight immunoprecipitation step in a cold room with 30 µl of V5 bead slurry and constant rotation.
On the following day, immunoprecipitations were washed three times with 1 ml of wash buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 5 mM MgCl 2 ) and resuspended in 25 µl of complete 1× ATPase Assay Reaction Buffer (10 mM Tris pH 7.5, 50 mM NaCl, 5 mM MgCl 2 , 20% glycerol) with reaction reagents (0.1 mg ml -1 BSA, 1 mM DTT, 4 mM ATP, 0.1-0.5 µg µl -1 DNA) and transferred to PCR tubes. The consumption reaction was incubated at 37 C for 1 h. Following ATP hydrolysis, beads were separated from the assay and 20 µl of ATPase reaction was transferred to an opaque, white 384-well plate.ADP-Glo reagent (20 µl) was added and incubated at room temp for 40 min. Then, 4 µl of ADP-Glo detection substrate was added to the reaction and incubated for 1 h. Luminescence was recorded on SpectraMax with an integration time of 0.25-1.0 s well -1 . Differential salt extraction. Differential salt extraction was performed as previously described 21 .
Genetic interactions. To call SMARCA4/2 dual loss genetic interactions from screening data, we utilized the MINGLE framework 16 with a few modifications. CRISPR screening data and cell line data were downloaded from the Depmap Public 18Q2 dataset (https://depmap.org/portal/download/all/). Cell lines were Letters NATURe GeNeTICS designated as SMARCA4/2-dual-deficient from literature references (BIN-67, COV434, OVK18) 17 or if the cell line exhibited low gene expression of SMARCA2 (reads per kilobase of transcript, per million mapped reads (RPKM) < 2), exhibited biallelic damaging mutations on SMARCA4 and did not exhibit a strong dependency on SMARCA4 or SMARCA4 (H1581 or H23). Differential dependency was calculated directly from CERES scores, significance was assessed using a Wilcoxon rank-sum test and P values were adjusted for multiple comparisons with Benjamini-Hochberg correction. Differential dependencies with false discovery rate <0.25 were reported as significant. Pi scores and graphical output were performed as in the MINGLE pipeline.
ChIP-seq. We performed mSWI/SNF chromatin immunoprecipitation using a modified version of a protocol previously described 21, 31, 32 . In brief, cells were fixed in 1% formaldehyde at 37 °C for 10 min, quenched in 2.5 M glycine and snap frozen. Cells were thawed and lysed, and then the prepared nuclei were placed in a Covaris miliTube and sonicated for 20 min on a Covaris AFA Sonicator at standard settings (140 peak incident power(PIP), 5 W, 10% duty factor). The equivalent of 6-10 million cells were used in each immunoprecipitation. Three micrograms of antibodies to the following were used: DPF2 ( Immunoprecipitates were washed in 150 and 500 mM NaCl wash buffers as well as a lithium chloride wash. Protein-DNA fragments were eluted using an sodium dodecyl sulfate/DTT buffer and reverse crosslinked overnight. DNA was captured with SPRI beads (Agilent). Rubicon library prep was used to generate libraries, which were sequenced on an Illumina NextSeq 500. ChIP-seq immunoprecipitations for each antibody were performed in singlicate across each of the rescue conditions; overlaps of antibodies targeting two distinct epitopes or subunits were used for analyses.
ChIP analysis. For alignment of ChIP-Seq data, Bowtie2, version 2.1.0 was used to map reads to the hg19 human reference genome, using the parameter -k 1 to search for at most one distinct alignment. All downstream analysis was performed on bam files, with duplicates removed using the samtools rmdup command.
Peaks were called using MACS 2.0 at a q value cutoff of 0.001 using the narrow peak setting, with the exception of ARID2 peaks,which were called using the broad peak setting. Peaks that fell within ENCODE blacklisted regions or were mapped to unmappable chromosomes (not chr1-22, X or Y) were removed. ChIP-seq track densities were generated per million mapped reads with MACS 2.0 using the -B -SPMR options, sorted with the bedtools sort command, and converted to bigwig files using the bedGraphToBigWig tool from ENCODE. Tracks were visualized using the Integrative Genomics Viewer (IGV). Overlaps for ChIP Venn diagrams were created using the ChIPPeakAnno bioconductor package.
ChIP peak sets. All peak sets used in the paper were derived from at least two complementary ChIP-seq experiments (using antibodies designed to two distinct subunits on mSWI/SNF complexes) from the same experimental condition.
The residual complex peak set was defined as the union between peaks identified in BIN-67 + control rescue (any of peaks ARID2, DPF2 or SMARCC1). Both control DPF2 and ARID2 peaks analyzed in Fig. 2 were intersected with SMARCC1 peaks from the same experimental condition. Both SS18 and PBAF peaks following rescue of SMARCA4 in Fig. 2 were intersected with SMARCA4 peaks from the same experimental condition. Intersections were performed by using pybedtools with SS18 or ARID2 considered the ' A' peak in the comparison and the -wa option set to True.
BAF activity-independent peaks were defined as SS18 peaks (intersected with SMARCA4 peaks as noted above) that were also found in the SS18 ChIP performed in SMARCA4 K785R rescue. The remaining SS18 peaks were annotated as activity-dependent. PBAF activity-independent peaks were similarly defined, but with ARID2 rather than SS18. Enhancers (Fig. 4a) were defined as H3K4me1 peaks in the WT SMARCA4 rescue condition that overlapped ATAC-seq peaks in the same condition. TSSs were defined by using annotables 0.1.91 grch37, and active TSSs (used in Fig. 5a ) were defined as those whose transcripts had RPKM > 2 in the SMARCA4 WT rescue in BIN-67 cells.
ChIP occupancy scatterplots. Read counts across peak sets of interest were calculated by calling Rsubread featureCounts() on duplicate removed bam files. These values were divided by the total number of mapped reads divided by one million, giving a normalized value of reads per million mapped reads for each interval in the input bed. Scatterplots were plotted with the R function smoothScatter. Fig. 2g were analyzed with the ChIPSeeker package using default settings 34 .
ChIP feature distributions. Peak sets in
ChIP heatmaps and metagene plots. Heatmaps of ChIP occupancy were generated created using HTSeq. To account for the 200 base pairs (bp) average fragment length selected for in sonication, fragment length was extended by 200 bp from the edge of each genomic interval. Total read counts for each interval were normalized to reads per million mapped reads. For each antibody the resulting matrix has a width of 4 kb and the number of rows corresponding to the number of peaks in the indicated set. Strandedness of the interval was not considered except for the directional TSS metagene plots, in which the average readcount per million mapped reads was plotted for each sample to construct an average profile over TSSs ( Fig. 5d and Supplementary  Fig. 4b ). Heatmaps were visualized using matplotlib in Python. Heatmaps were ordered by the maximum value in each matrix row of the indicated antibody.
ATAC-seq. ATAC-seq was performed as described previously 35 . In particular, 50,000 cells were harvested for each condition as suggested. Libraries were prepared using the suggested barcodes and sequenced on a paired-end Illumina NextSeq 500, with four samples on a single paired-end lane. All rescue and control experiments were performed in duplicate, and sequencing data were aligned as previously described 36 . In detail, ATAC-seq reads were paired and trimmed to 30 bp with Trimmomatic 0.36, then aligned to the hg19 genome with Bowtie2 v2.2.9 with the -X parameter set to 2000. Picard MarkDuplicates was used remove duplicate reads, and then bam files were further filtered by using the samtools view function with settings -F 256 -f 2 -q 30. Reads in ENCODE blacklisted regions were removed by using bedtools v2.26 intersect with the -v parameter True. Replicate bam files were merged by using Samtools v0.1.19 merge. These merged bam files were used for all downstream analysis. Bedgraph files were generated with the BedTools function genomeCoverageBed with the -pc option true. These bedgraphs were converted to BigWig format by using the bedGraphToBigWig script downloaded from UCSC. ATAC peaks were called by using MACS2 callpeak with a q value cutoff of 1 × 10 -3 and the paramaters --nomodel --shift -150 --extsize 200. Peaks that fell into unmappable chromosomes were removed. All rescue and control experiments were performed in duplicate, and sequencing data merged into a single file for processing.
RNA-seq.
One million cells of each condition were harvested using the Qiagen RNeasy kit, then 1 µg was DNase treated and used in the Illumina TruSeq Stranded mRNA library prep kit. All samples were validated as having an RNA integrity number (RIN) > 0.6 on a BioAnalyzer. Libraries were sequenced on an Illumina NextSeq 500. All rescue conditions were performed in replicate, with the SMARCA4 rescue performed in triplicate.
After sequencing, RNA-seq data reads were mapped using default parameters to hg19 using STAR version 2.5.2a. Differential genes were called using DESeq2. RPKM values were calculated using GFOLD version 1.1.4. Unless otherwise noted, log 2 fold change and Bonferri-corrected P values were generated using DESEQ2, with reads mapped using Rsubread. Genes were considered to have changed significantly if they had an adjusted P < 0.05 and a log 2 fold change of at least 2.
Clustering of differentially expressed genes. The log 2 fold change of differentially expressed genes in the SMARCA4 rescue condition was plotted with the pheatmap R package across all four experimental conditions tested (SMARCA4 K785R, SMARCA4 T910M, SMARCA4 WT and SMARCA2 WT). Clustering was performed with complete linkage clustering and Euclidian distance, and a cluster number of 3 was chosen for further analysis.
Gene Ontology enrichment. Gene Ontology term enrichment was performed with the GOrilla web tool (http://cbl-gorilla.cs.technion.ac.il) 37 , using each of the three differentially expressed gene clusters as target gene lists, and the set of expressed genes among BIN-67 RNA-seq experiments (RPKM > 2, resulting in 13,189 genes) as background.
Target gene assignment and enrichment. Genes were annotated as targets of BAF regulation if there was at least one BAF peak within 30 kb of the TSS of that gene. Genes were annotated as PBAF targets in the same fashion. Target genes were split between activity-dependent and activity-independent groups based on which peak set was more abundant within the 30-kb window around the TSS.
For each of the three differentially regulated gene clusters, over-representation of BAF and PBAF target genes was assessed with a one-sided Fisher's exact test against the background of all expressed genes (13,189 in total).
Gene set enrichment analysis of target genes. Gene set enrichment analysis was performed with GSEA software 38 on the MSigDB C2 gene sets using differential expression data following the reintroduction of SMARCA4 WT. Gene sets that were enriched for upregulated genes with a family-wise error rate P < 0.01 were used for downstream analysis. Over-representation of BAF activity-dependent or activity-independent target genes among upregulated genes within these gene sets was calculated with a one-sided Fisher's exact test against the background of all upregulated genes (533 in total).
Primary tumor and normal ovarian data. Raw RNA abundance counts for ten primary SCCOHT tumors (SRA SRP052896) and 108 primary ovary samples (GTEx) were computed using the recount2 pipeline 39 (PMID: 28398307). MicroRNA and small non-coding RNA transcripts were removed from RNA-seq for SCCOHT tumors and wild type ovary tissue. Due to considerable batch differences Letters NATURe GeNeTICS between the two samples, we used a more conservative non-parametric rank-based method to identify differentially expressed genes. Transcripts were ranked by using a mean rank across all tumor or wild-type samples, which was calculated for each transcript. The difference in mean rank was used to determine differentially expressed transcripts between the samples. Specifically, the top and bottom 5% of differentially ranked genes between conditions were used for further analysis. 
Code availability
Code to generate figures is available at https://github.com/joshbiology/sccoht/. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Data quality epitopes targeting the same complex (SS18 and SMARCA4, ARID2 and SMARCA4).
Software
ChIP occupancy scatterplots Read count across peak sets of interest were calculated by calling the Rsubread bioconductor package function featureCounts() on duplicate removed bam files. These values were divided by the total number of mapped reads divided by one million, giving a normalized value of reads per million mapped reads for each interval in the input bed. Scatterplots were plotted with the R function smoothScatter. ChIP heatmaps Heatmaps of ChIP occupancy were generated created using HTSeq. To account for the 200bp average fragment length selected for in sonication, fragment length was extended 200 bp from the edge of each genomic interval. Total read counts for each interval were normalized to reads per million mapped reads (RPM). For each antibody the resulting matrix has a width of 4 kb and a height of the number of peaks in the indicated set. Strandedness of the interval was not considered except for the direction TSS plots ( Figure 4D, Supplementary Figure 4A ). Heatmaps were visualized using matplotlib in 5 nature research | reporting summary April 2018 python. Heatmaps were ordered by the maximum value in each matrix row of the indicated antibody. All other plots were generated with ggplot2 in R. Custom code to generate figures are available upon request, and a public repository will be included at https://github.com/joshbiology/sccoht.
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